Company
Xinkanghe Biopharmac
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Xinkanghe Biopharmaceuticals was established in November 2015. Based on the world's cutting-edge scientific research results, the company is committed to the development of new targets or innovative combinations of drugs for tumors and autoimmune inflammatory diseases, and leads the research and development of innovative immunotherapy antibody drugs.
Loading relationship preview